Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayJun 04, 2019 1:40 pm

Medicine Man Technologies Inc. (MDCL) Starts Presentation at 9th Annual LD Micro Invitational

Medicine Man Technologies (OTC: MDCL) is a fully integrated operator in the cannabis industry, offering consulting, retail pharma-grade products, and turnkey solutions for cannabis cultivators for over a decade. Medicine Man Technologies is leveraging its expertise and intellectual property to vertically integrate retail, cultivation, formulation, and distribution operations. The company's client portfolio includes active and past clients in 18 states and seven countries. For more information, visit the company's website at www.medicinemantechnologies.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press…

Continue Reading

TuesdayJun 04, 2019 1:40 pm

Hoth Therapeutics Inc. (HOTH) Starts Presentation at 9th Annual LD Micro Invitational

Hoth Therapeutics (NASDAQ: HOTH) is a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. Hoth has exclusive worldwide rights to the BioLexa Platform for all indications in humans. The BioLexa Platform is a proprietary, patented, drug compound platform developed at the University of Cincinnati. The BioLexa Platform combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups by preventing the formation of infectious biofilms and the resulting clogging of sweat ducts. It is the first product candidate…

Continue Reading

TuesdayJun 04, 2019 1:40 pm

CBD Unlimited (EDXC) Starts Presentation at 9th Annual LD Micro Invitational

CBD Unlimited (OTC: EDXC), with its collaborative partners and consultants, develops and distributes two consumable product lines derived from Hemp, which is all-natural and rich in phyto-cannabinoids. Phyto-Bites is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two key technology products and services that launched in 2014. Both products provide essential solutions to promote regulatory compliance and full accountability through asset protection, inventory management, compliance and an “end of sale” technology integration. For more information, visit the company's website at…

Continue Reading

TuesdayJun 04, 2019 1:40 pm

CEL-SCI Corp. (CVM) Starts Presentation at 9th Annual LD Micro Invitational

CEL-SCI (NYSE: CVM) is a biotechnology company involved in the research and development of immunotherapy products for the treatment of cancer, autoimmune and infectious diseases. The company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances. CEL-SCI's vision is to change the way cancer is treated by developing novel immune-based therapies with potential to utilize the body's own immune defense system against the disease. CEL-SCI's lead investigational therapy, Multikine (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent directed at enabling the immune system to use the body's own anti-tumor immune response. For…

Continue Reading

TuesdayJun 04, 2019 1:20 pm

Kindred Biosciences Inc. (KIN) Starts Presentation at 9th Annual LD Micro Invitational

Kindred Biosciences (NASDAQ: KIN) is a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes. KindredBio's first approved drug is Mirataz for the management of weight…

Continue Reading

TuesdayJun 04, 2019 1:20 pm

Newgioco Group Inc. (NWGI) Starts Presentation at 9th Annual LD Micro Invitational

Newgioco Group (OTC: NWGI), together with its wholly owned subsidiaries, is a fully licensed and integrated online and land-based leisure gaming operator. The company conducts its business under the registered brand Newgioco primarily through its internet-based betting distribution network on its website, www.newgioco.it as well as retail neighborhood betting shops situated throughout Italy. The company offers its clients a full suite of leisure gaming products and services, such as sports betting, virtual sports, online casino, poker, bingo, interactive games and slots, as well as owning and operating an innovative betting platform (www.odissea.at) providing both B2B and B2C bet processing. For…

Continue Reading

TuesdayJun 04, 2019 1:20 pm

One Stop Systems Inc. (OSS) Starts Presentation at 9th Annual LD Micro Invitational

One Stop Systems (NASDAQ: OSS) designs and manufactures innovative specialized high-performance computing modules and systems, including customized servers, compute accelerators, expansion systems, flash storage arrays and ION Accelerator storage software. These products are used for deep learning, AI, defense, finance and entertainment applications, and empower scientists, engineers, creators and other professionals to push the boundaries of their industries. OSS utilizes the power of PCI Express, the latest GPU accelerators and NVMe storage to build award-winning systems, including many industry firsts, for OEMs and government customers. OSS products are available directly or through global distributors. For more information, visit the company's…

Continue Reading

TuesdayJun 04, 2019 1:20 pm

Digital Ally Inc. (DGLY) Starts Presentation at 9th Annual LD Micro Invitational

Digital Ally (NASDAQ: DGLY) specializes in the design and manufacturing of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, commercial fleets, and consumer use. Digital Ally’s complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide. For more information, visit the company's website at www.digitalallyinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

Continue Reading

TuesdayJun 04, 2019 1:00 pm

Australis Capital (CSE: AUSA) (AUSAF) Starts Presentation at 9th Annual LD Micro Invitational

Australis Capital (CSE: AUSA) (OTC: AUSAF), a spin-out of Aurora Cannabis, identifies and invests in the cannabis industry predominantly in the United States. Investments may include but are not limited to equity, debt or other securities of both public and private companies, financings in exchange for royalties or other distribution streams, and control stake acquisitions.  Australis adheres to stringent investment criteria and focuses on significant near and mid-term high-quality opportunities with strong return potentials while maintaining a steadfast commitment to governance and community. Australis' Board and management team have material experience with, and knowledge of, the cannabis space in the…

Continue Reading

TuesdayJun 04, 2019 1:00 pm

Biocept Inc (BIOC) Starts Presentation at 9th Annual LD Micro Invitational

Biocept (NASDAQ: BIOC) is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma.  Biocept uses its proprietary liquid biopsy technology to provide physicians with information for treating and monitoring patients diagnosed with cancer. The company's patented Target Selector™ liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in plasma (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient's disease and therapeutic options. For more information, visit the company's website…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000